Search

everythinglearnresearchcommunity

for

Search:↓

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Sparse hairs below frontal hairline can indicate early male balding.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.